NeuroTherapeutics Pharma ntprx.com


Public list: Pharma Startups (4740) Neuroscience Startups (942)

NeuroTherapeutics Pharma is a biopharmaceutical company developing therapies to treat pain, epilepsy, and other nervous system disorders. NTP is advancing compounds that act through a novel mechanism of action to create a new class of medicines with potential broad application across a range of neurological and neuropsychiatric conditions.

NeuroTherapeutics Pharma is a biopharmaceutical company developing therapies to treat pain, epilepsy, and other nervous system disorders. NTP is advancing compounds that act through a novel mechanism of action to create a new class of medicines with ...Show all

Company (Dead / Inactive)

Phone: 773-444-4180

Fax:

8750 W. Bryn Mawr Avenue
Suite 440
Chicago, 60631
Illinois, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
NeuroTherapeutics Pharma $60.7M May 1, 2013
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related NeuroTherapeutics Pharma Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
MPM CapitalVenture CapitalCambridge, Massachusetts, United StatesSeries C, Series B
De Novo VenturesVenture CapitalMenlo Park, California, United StatesSeries B
Novo HoldingsHolding CompanyHellerup, DenmarkSeries C, Debt
F-Prime CapitalVenture CapitalCambridge, Massachusetts, United StatesSeries C, Series B
Pfizer Venture InvestmentsCorporate VentureNew York, New York, United StatesSeries C, Series B
See all 9 investors

Competitors

Company Status Description Investors
See all 16 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Methods and compositions for the treatment of neuropsychiatric disorders Oct 17, 2005 Aug 30, 2011 Patent